These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 15325198
1. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma. Freudenberg LS, Schueler AO, Beyer T, Antoch G, Kühl H, Bornfeld N, Bockisch A, Egelhof T. Surv Ophthalmol; 2004; 49(5):537-40. PubMed ID: 15325198 [Abstract] [Full Text] [Related]
2. Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET). Servois V, Mariani P, Malhaire C, Petras S, Piperno-Neumann S, Plancher C, Levy-Gabriel C, Lumbroso-le Rouic L, Desjardins L, Salmon RJ. Eur J Surg Oncol; 2010 Feb; 36(2):189-94. PubMed ID: 19775851 [Abstract] [Full Text] [Related]
3. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S. Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094 [Abstract] [Full Text] [Related]
4. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment. Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, de Klerk JM, Oyen WJ, Meijer S, Hoekstra HJ. J Clin Oncol; 2009 Oct 01; 27(28):4774-80. PubMed ID: 19720925 [Abstract] [Full Text] [Related]
5. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. Messa C, Ceresoli GL, Rizzo G, Artioli D, Cattaneo M, Castellone P, Gregorc V, Picchio M, Landoni C, Fazio F. Q J Nucl Med Mol Imaging; 2005 Sep 01; 49(3):259-66. PubMed ID: 16172572 [Abstract] [Full Text] [Related]
10. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors]. Wu ZJ, Zhang YX, Wei H, Jia Q. Zhonghua Yi Xue Za Zhi; 2007 Aug 28; 87(32):2253-6. PubMed ID: 18001544 [Abstract] [Full Text] [Related]
19. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection. Quaia E, Tona G, Gelain F, Lubin E, Pizzolato R, Boscolo E, Bussoli L. Acta Radiol; 2008 Nov 28; 49(9):995-1004. PubMed ID: 18651256 [Abstract] [Full Text] [Related]
20. Association of positive dual-modality positron emission tomography/computed tomography imaging of primary choroidal melanoma with chromosome 3 loss and tumor size. McCannel TA, Reddy S, Burgess BL, Auerbach M. Retina; 2010 Jan 28; 30(1):146-51. PubMed ID: 20010323 [Abstract] [Full Text] [Related] Page: [Next] [New Search]